Kirkland & Ellis is advising funds managed by Oaktree Capital Management, L.P. (“Oaktree”) on the acquisition of a stake in NL - HOLDING GmbH. Oaktree is a leader among global investment managers specializing in alternative investments, with $100 billion in assets under management as of 30 September 2017. The firm emphasizes an opportunistic, value-oriented and risk-controlled approach to investments in distressed debt, corporate debt (including high yield debt and senior loans), control investing, convertible securities, real estate and listed equities.  Headquartered in Los Angeles, the firm has over 900 employees and offices in 18 cities worldwide.  For additional information, please visit Oaktree’s website at oaktreecapital.com. Founded in 2015, NL - HOLDING GmbH focuses on assisted reproductive technology ("ART"). The group currently has 16 subsidiaries, predominantly in Germany, the Czech Republic, Italy, Switzerland and Spain. Kirkland & Ellis advises Oaktree with the following team: Munich: Volkmar Bruckner (Private Equity/M&A), Jörg Kirchner (Private Equity/M&A); Associates: Mark Aschenbrenner, Greta-Josefin Harnisch (both Private Equity/M&A) London: Stuart Boyd (Private Equity/M&A), Sarah Jordan (Antitrust); Associate: James Parkinson (Antitrust) Further advisor to Oaktree: Giese & Partner Prague: Ernst Giese; Associates: Marie Zámecníková, Radek Lopata (all Czech law)